Eli Lilly CEO David Ricks' pay rises 26% for 2025

Reuters06:09

Eli Lilly CEO David Ricks' pay rises 26% for 2025

March 20 (Reuters) - Eli Lilly LLY.N paid its chief executive David Ricks $36.7 million in 2025, up roughly 25.7% from the previous year, a regulatory filing showed on Friday.

Here are some details:

Ricks, who has led the company since 2017, received compensation that included salary, stock awards and incentive payments.
The jump in pay reflects a year in which Lilly continued to expand its position in the drug markets, driven largely by soaring demand for its obesity and diabetes drugs.
The company's weight-loss drug Zepbound and diabetes treatment Mounjaro have become two of the most closely watched products in the global pharmaceutical industry, helping push Lilly's market value to record highs.
In 2025, Mounjaro and Zepbound together generated $36.51 billion of the company's total revenue of $65.18 billion.
Last year, Lilly became the first drugmaker to hit the $1 trillion mark in market value, entering the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Lilly's stock is up 38.1% in 2025 vs. 30.4% in 2024
CEO Ricks' earnings consist of a $1.7 million salary, $23.3 million in stock awards, $6.5 million in non‑stock incentive pay, $4.45 million from pension value changes and $736,201 in other compensation, according to the filing.

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

1

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2621475204?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-21 06:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2621475204","market":"nz","top_or_hot":-1,"title":"Eli Lilly CEO David Ricks' pay rises 26% for 2025","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Eli Lilly CEO David Ricks' pay rises 26% for 2025 </title></head><body><p>\n<span>March 20 (Reuters)</span><span> - </span>Eli Lilly <span>LLY.N</span> paid its chief executive David Ricks $36.7 million in 2025, up roughly 25.7% from the previous year, a regulatory filing showed on Friday.</p><p>Here are some details: </p><ul><li><p>Ricks, who has led the company since 2017, received compensation that included salary, stock awards and incentive payments. </p></li><li><p>The jump in pay reflects a year in which Lilly continued to expand its position in the drug markets, driven largely by soaring demand for its obesity and diabetes drugs. </p></li><li><p>The company's weight-loss drug Zepbound and diabetes treatment Mounjaro have become two of the most closely watched products in the global pharmaceutical industry, helping push Lilly's market value to record highs.</p></li><li><p>In 2025, Mounjaro and Zepbound together generated $36.51 billion of the company's total revenue of $65.18 billion.</p></li><li><p>Last year, Lilly became the first drugmaker to hit the <span>$1 trillion</span> mark in market value, entering the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.</p></li><li><p>Lilly's stock is up 38.1% in 2025 vs. 30.4% in 2024</p></li><li><p>CEO Ricks' earnings consist of a $1.7 million salary, $23.3 million in stock awards, $6.5 million in non‑stock incentive pay, $4.45 million from pension value changes and $736,201 in other compensation, according to the filing.</p></li></ul><p> (Reporting by Kamal Choudhury in Bengaluru)</p><p> ((Kamal.Choudhury@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly CEO David Ricks' pay rises 26% for 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly CEO David Ricks' pay rises 26% for 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-21 06:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Eli Lilly CEO David Ricks' pay rises 26% for 2025 </title></head><body><p>\n<span>March 20 (Reuters)</span><span> - </span>Eli Lilly <span>LLY.N</span> paid its chief executive David Ricks $36.7 million in 2025, up roughly 25.7% from the previous year, a regulatory filing showed on Friday.</p><p>Here are some details: </p><ul><li><p>Ricks, who has led the company since 2017, received compensation that included salary, stock awards and incentive payments. </p></li><li><p>The jump in pay reflects a year in which Lilly continued to expand its position in the drug markets, driven largely by soaring demand for its obesity and diabetes drugs. </p></li><li><p>The company's weight-loss drug Zepbound and diabetes treatment Mounjaro have become two of the most closely watched products in the global pharmaceutical industry, helping push Lilly's market value to record highs.</p></li><li><p>In 2025, Mounjaro and Zepbound together generated $36.51 billion of the company's total revenue of $65.18 billion.</p></li><li><p>Last year, Lilly became the first drugmaker to hit the <span>$1 trillion</span> mark in market value, entering the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.</p></li><li><p>Lilly's stock is up 38.1% in 2025 vs. 30.4% in 2024</p></li><li><p>CEO Ricks' earnings consist of a $1.7 million salary, $23.3 million in stock awards, $6.5 million in non‑stock incentive pay, $4.45 million from pension value changes and $736,201 in other compensation, according to the filing.</p></li></ul><p> (Reporting by Kamal Choudhury in Bengaluru)</p><p> ((Kamal.Choudhury@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE0009355771.USD","symbol_name":"骏利亨德森环球生命科技A Acc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL4N4081V6:1","article_id":"2621475204","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2621475204","pubTimestamp":1774044597,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Eli Lilly CEO David Ricks' pay rises 26% for 2025  March 20 (Reuters) - Eli Lilly LLY.N paid its chief executive David Ricks $36.7 million in 2025, up roughly 25.7% from the previous year, a regulator","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE0009355771.USD":"骏利亨德森环球生命科技A Acc","BK4585":"ETF&股票定投概念","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","LU2237443895.HKD":"abrdn SICAV I -  GLOBAL DYNAMIC DIVIDEND \"A\" (HKD) ACC","IE00BWXC8680.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5\" (SGD) ACC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","SG9999014898.SGD":"United Global Quality Growth Fund Dis SGD","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU1917777945.USD":"安联专题基金Cl AT Acc","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","ELIL":"2倍做多LLY ETF-Direxion","LU1868837136.USD":"CT (LUX) I AMERICAN \"8\" (USD) ACC","SGXZ99366536.SGD":"United Global Innovation A Acc SGD-H","LU1323610961.USD":"UBS (LUX) EQUITY SICAV - LONG TERM THEMES (USD) \"P\" (USD) ACC","IE00BJJMRX11.SGD":"Janus Henderson Balanced A Acc SGD","ELIS":"1倍做空LLY ETF-Direxion","LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","IE0004445015.USD":"JANUS HENDERSON BALANCED \"A2\" (USD) ACC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","BK4588":"碎股","LLII":"REX LLY Growth & Income ETF","LU0097036916.USD":"贝莱德美国增长A2 USD","LU2211815571.USD":"ALLIANZ POSITIVE CHANGE \"AT\" (USD) ACC","IE00B4JS1V06.HKD":"JANUS HENDERSON BALANCED \"A2\" (HKD) ACC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU0471298777.SGD":"Blackrock Nutrition A2 SGD-H","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","LLYX":"2倍做多LLY ETF-Defiance","BK4599":"减肥药","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LLYZ":"2倍做空LLY ETF-Defiance","LU2417539215.USD":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LLY":"礼来","LU2746668461.USD":"MANULIFE DYNAMIC LEADERS \"AA\" (USD) ACC","LU2750360641.GBP":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (GBPHDG) INC","LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","LU2360106947.USD":"BGF NUTRITION \"A4\" (USD) INC","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","IE00BN29S564.USD":"JANUS HENDERSON BALANCED \"A3\" (USD) INC","IE0004445239.USD":"JANUS HENDERSON US FORTY \"A2\" (USD) ACC","LU1069344957.HKD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (HKD) INC","LU2108987350.USD":"UBS (LUX) EQUITY SICAV GLOBAL OPPORTUNITY SUSTAINABLE (USD) \"P\" (USD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","LU0203202063.USD":"AB SICAV I - ALL MARKET INCOME PORTFOLIO \"A2X\" (USD) ACC"},"translate_title":"礼来公司首席执行官David Ricks 2025年薪酬将上涨26%","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LLYZ":0.6,"ELIS":0.6,"ELIL":0.6,"LLII":0.6,"LLYX":0.6,"LLY":0.9},"content_text":"Eli Lilly CEO David Ricks' pay rises 26% for 2025 \nMarch 20 (Reuters) - Eli Lilly LLY.N paid its chief executive David Ricks $36.7 million in 2025, up roughly 25.7% from the previous year, a regulatory filing showed on Friday.Here are some details: Ricks, who has led the company since 2017, received compensation that included salary, stock awards and incentive payments. The jump in pay reflects a year in which Lilly continued to expand its position in the drug markets, driven largely by soaring demand for its obesity and diabetes drugs. The company's weight-loss drug Zepbound and diabetes treatment Mounjaro have become two of the most closely watched products in the global pharmaceutical industry, helping push Lilly's market value to record highs.In 2025, Mounjaro and Zepbound together generated $36.51 billion of the company's total revenue of $65.18 billion.Last year, Lilly became the first drugmaker to hit the $1 trillion mark in market value, entering the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.Lilly's stock is up 38.1% in 2025 vs. 30.4% in 2024CEO Ricks' earnings consist of a $1.7 million salary, $23.3 million in stock awards, $6.5 million in non‑stock incentive pay, $4.45 million from pension value changes and $736,201 in other compensation, according to the filing. (Reporting by Kamal Choudhury in Bengaluru) ((Kamal.Choudhury@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2621475204","isCrawlerRequest":true}